|
Biotech
> Otonomy ($OTIC) appoints Dr. Dean Hakanson as chief medical officer. Release
> Galmed Pharma ($GLMD) names George Tonelli vice president of clinical operations. Release
> Karyopharm ($KPTI) adds Dr. Mikael Dolsten to its board of directors. Release
> Evofem names David Friend as senior vice president of product development. Release
> Corium International adds Eric Bjerkholt to its board of directors. Release
> Midatech Pharma announced that Jeff Brown is stepping down from its board of directors effective April 30. Release
> Clinigen is seeking a new chief financial officer to succeed Robin Sibson when he retires in 2015 or 2016. Release
> Iroko Pharma adds Pierre Legault to its board of directors. Release
> Immunocore appoints Dr. Christina Coughlin as chief medical officer. Release
> Immunogen ($IMGN) appoints Dr. Anna Berkenblit as vice president and chief medical officer. Release
> Blaze Bioscience adds Dr. Jan Öhrström to its board of directors. Release
> DelMar Pharma appoints Erich Mohr to its board of directors. Release
> Retrophin ($RTRX) adds John Kozarich to its board as an independent director and names Jeffrey Meckler as chairman. Release
> Orexigen ($OREX) hired Tom Cannell as its chief commercial officer. Release
> Tyrogenex appointed Michael Webb as its president and CEO. Release
> Tesaro ($TSRO) brought on Joseph Farmer as its senior vice president and general counsel. Release
> Michael Levitz resigned from medical imaging company Analogic ($ALOG), where he served as CFO. Release
> Paul Anderson joined InMed's scientific advisory board. Release
Pharma
> EMD Serono, the U.S. subsidiary of Merck KGaA, appoints Dr. Frederick Munschauer as vice president of medical affairs, neurology and immunology. Release
Animal Health
> Nexvet ($NVET) appoints former head of Novartis Animal Health Dr. George Gunn as nonexecutive chairman of its board. Release
|
